Latest Whitepapers
Whitepaper
Advances in Cell Therapy
This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.
Whitepaper
Embracing Data-Driven Modeling Approaches Into Biopharmaceutical Processing
This article explores new workflows using data-driven modeling to improve culture medium and new control algorithms allowing for better modulation within the bioprocess design space.
Whitepaper
Cell Culture – Good Practice and Advanced Methods
This article explores how quality control can improve protocol standardization, enhance scalability and ensure that cultures meet regulatory criteria.
Whitepaper
Applications of Mass Spectrometry in Biopharmaceutical Analysis
The sensitivity and specificity of mass spectrometry (MS) has made it an indispensable tool for biopharmaceutical analysis, ensuring the safety and efficacy of biologics.
Whitepaper
High-Throughput Screening Methods for Drug Discovery
Due to the sheer number of possible compounds available, pharmaceutical companies have been adopting high-throughput screening (HTS) methods that can screen chemical libraries rapidly and inexpensively to identify the most promising compounds with activity against a specific biological target.
Whitepaper
Expediting Drug Discovery Using Novel Target-Based Approaches
Innovative strategies to shorten the research and development cycle, increase process efficiency and expedite the drug discovery process are needed.
Whitepaper
Automated Epitope Binning in a Single Assay
Binding affinity is a significant factor to consider. However, relying solely on affinity can be problematic, as the highest affinity mAbs may not exhibit optimal activity. To ensure the best lead candidates, it is crucial to consider factors like specificity, selectivity and biological relevance.
Whitepaper
Model Neurodegenerative Disease Traits More Closely
This whitepaper highlights how PFFs could become the breakthrough modeling platform for scientists to discover and develop the next therapeutic for neurodegenerative diseases.
Whitepaper
Select Better Antibodies Using NGS Data
This whitepaper explores the cutting-edge cloud-based antibody selection tools, that provide confident and timely antibody selection. It also highlights the latest analysis software for independent, intricate analyses and optimal antibody selection.
Whitepaper
Optimize Project Management in the DMTA Cycle
This whitepaper highlights how the latest software can help researchers overcome the uncertainties in drug discovery and enable efficient compound design, synthesis and progression tracking.
Advertisement